The Cooper Companies, Inc. (NASDAQ:COO) Receives $81.85 Average PT from Brokerages

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have earned a consensus rating of “Hold” from the sixteen research firms that are covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a sell rating, five have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $81.8462.

A number of equities research analysts have commented on the company. JPMorgan Chase & Co. decreased their price objective on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. Weiss Ratings downgraded Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. Needham & Company LLC reduced their price target on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Citigroup reissued a “neutral” rating and issued a $76.00 price target (up from $69.00) on shares of Cooper Companies in a research report on Wednesday, July 8th. Finally, Wells Fargo & Company restated a “sell” rating and set a $66.00 price target (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th.

Institutional Investors Weigh In On Cooper Companies

A number of institutional investors have recently modified their holdings of the stock. JANA Partners Management LP acquired a new position in Cooper Companies in the 3rd quarter worth about $166,917,000. Alecta Tjanstepension Omsesidigt lifted its holdings in shares of Cooper Companies by 15.8% during the 3rd quarter. Alecta Tjanstepension Omsesidigt now owns 1,563,000 shares of the medical device company’s stock valued at $107,112,000 after buying an additional 213,500 shares during the last quarter. DAVENPORT & Co LLC lifted its holdings in shares of Cooper Companies by 1,359.7% during the 4th quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock valued at $46,642,000 after buying an additional 528,346 shares during the last quarter. Swiss Life Asset Management Ltd grew its stake in shares of Cooper Companies by 63.9% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 49,409 shares of the medical device company’s stock valued at $3,387,000 after buying an additional 19,264 shares in the last quarter. Finally, Fluent Financial LLC bought a new stake in shares of Cooper Companies in the 4th quarter valued at approximately $3,517,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Price Performance

COO opened at $71.71 on Monday. The stock has a fifty day moving average of $66.24 and a 200-day moving average of $72.52. The firm has a market capitalization of $13.99 billion, a P/E ratio of 60.77, a PEG ratio of 1.87 and a beta of 0.84. Cooper Companies has a 12-month low of $58.89 and a 12-month high of $89.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter last year, the firm posted $0.96 earnings per share. Cooper Companies’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts forecast that Cooper Companies will post 4.63 EPS for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.